Sol-Gel Technologies SLGL
NASDAQ SLGL
$74.28 +2.03 (+2.81%)
At close: Sep 30, 2026 · 4:00 PM EDT

Sol-Gel Technologies (SLGL) Current Deferred Revenue (2016 - 2021)

Updated

Sol-Gel Technologies' Current Deferred Revenue came in at $5.25 million for Q3 2021.

Analysis

Sol-Gel Technologies (SLGL) Current Deferred Revenue (2016 - 2021) Analysis & Trends

At the end of FY2017, Sol-Gel Technologies' Current Deferred Revenue was $13,000, down 98.4% from FY2016.

  • Going back by year, Current Deferred Revenue was $823,000 in FY2016 and -$625,000 in FY2015.
  • The Q3 2021 figure represents the lowest quarterly Current Deferred Revenue since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Sol-Gel Technologies 206.96 Mn 61.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 5.25 Mn
Sep 30, 2018 122,000.00
Jun 30, 2018 72,000.00
Dec 31, 2017 13,000.00
Dec 31, 2016 823,000.00
API Access

Sol-Gel Technologies Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SLGL&period=max&api_key=YOUR_API_KEY